5AE

4-amino-1-(beta-D-ribofuranosyl)-1,3,5-triazin-2(1H)-one

Created:	2014-05-19
Last modified:	2021-03-01

Find Related PDB Entry
1 entries where 5AE is found as a standalone ligand

Find related ligands: Help
Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	29
Chiral Atom Count	4
Bond Count	30
Aromatic Bond Count	0

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	4-amino-1-(beta-D-ribofuranosyl)-1,3,5-triazin-2(1H)-one
Synonyms	5-azacytidine
Systematic Name (OpenEye OEToolkits)	4-azanyl-1-[(2R,3R,4S,5R)-5-(hydroxymethyl)-3,4-bis(oxidanyl)oxolan-2-yl]-1,3,5-triazin-2-one
Formula	C₈ H₁₂ N₄ O₅
Molecular Weight	244.205
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	O=C1N=C(N=CN1C2OC(C(O)C2O)CO)N
SMILES	CACTVS	3.385	NC1=NC(=O)N(C=N1)[CH]2O[CH](CO)[CH](O)[CH]2O
SMILES	OpenEye OEToolkits	1.7.6	C1=NC(=NC(=O)N1C2C(C(C(O2)CO)O)O)N
Canonical SMILES	CACTVS	3.385	NC1=NC(=O)N(C=N1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O
Canonical SMILES	OpenEye OEToolkits	1.7.6	C1=NC(=NC(=O)N1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)N
InChI	InChI	1.03	InChI=1S/C8H12N4O5/c9-7-10-2-12(8(16)11-7)6-5(15)4(14)3(1-13)17-6/h2-6,13-15H,1H2,(H2,9,11,16)/t3-,4-,5-,6-/m1/s1
InChIKey	InChI	1.03	NMUSYJAQQFHJEW-KVTDHHQDSA-N

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

DrugBank ID	DB00928
Name	Azacitidine
Description	A pyrimidine nucleoside analogue that inhibits DNA methyltransferase, impairing DNA methylation. It is also an antimetabolite of cytidine, incorporated primarily into RNA. Azacytidine has been used as an antineoplastic agent.
Synonyms	Azacitidinum Azacytidine Azacitidine Azacitidina 5-azacytidine 4-amino-1-beta-D-ribofuranosyl-s-triazin-2(1H)-one
Indication	For treatment of patients with the following French-American-British myelodysplastic syndrome subtypes: refractory anemia or refractory anemia with ringed sideroblasts (if accompanied by neutropenia or thrombocytopenia or requiring transfusions), refractory anemia with excess blasts, refractory anemia with excess blasts in transformation (now classified as acute myelogenous leukemia with multilineage dysplasia), and chronic myelomonocytic leukemia.
Categories	Antimetabolites Antineoplastic Agents Antineoplastic and Immunomodulating Agents Aza Compounds Cytidine Deaminase Substrates Drugs that are Mainly Renally Excreted Enzyme Inhibitors Immunosuppressive Agents Myelosuppressive Agents Narrow Therapeutic Index Drugs Noxae Nucleic Acid Synthesis Inhibitors Nucleic Acids, Nucleotides, and Nucleosides Nucleoside Metabolic Inhibitor Nucleosides Pyrimidine Analogues Pyrimidine Nucleosides Pyrimidines Ribonucleosides Toxic Actions
ATC-Code	L01BC07
CAS number	320-67-2

Drug Targets

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

Name	Target Sequence	Pharmacological Action	Actions
DNA (cytosine-5)-methyltransferase 1	MPARTAPARVPTLAVPAISLPDDVRRRLKDLERDSLTEKECVKEKLNLLH...	unknown	inhibitor
RNA	-	unknown	other
DNA	-	unknown	other
Cytidine deaminase	MAQKRPACTLKPECVQQLLVCSQEAKKSAYCPYSHFPVGAALLTQEGRIF...	unknown	substrate

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682